NEW YORK (GenomeWeb) – Becton Dickinson's BD Life Sciences segment said today that it has obtained CE mark for the BD Max CT/GC/TV and CT/GC assays.
The assays are for detecting Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis from a single specimen in one run. Urine samples can be used for testing, as well as self-collected vaginal swabs and clinician-collected endocervical swabs, BD said. Once loaded onto the BD Max platform, results can be generated in less than three hours.
The BD Max system combines automated extraction, real-time PCR amplification, and detection.